|
Name |
(1R,2R,5S,8S,9S,10R,11R,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
|
Molecular Formula | C19H23O6- | |
IUPAC Name* |
(1R,2R,5S,8S,9S,10R,11R,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
|
|
SMILES |
C[C@]12[C@H](CC[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@](C4)(C(=C)C5)O)C(=O)[O-])OC2=O)O
|
|
InChI |
InChI=1S/C19H24O6/c1-9-7-17-8-18(9,24)5-3-10(17)19-6-4-11(20)16(2,15(23)25-19)13(19)12(17)14(21)22/h10-13,20,24H,1,3-8H2,2H3,(H,21,22)/p-1/t10-,11+,12-,13-,16+,17+,18+,19-/m1/s1
|
|
InChIKey |
JLJLRLWOEMWYQK-SNTJWBGVSA-M
|
|
Synonyms |
GA1
|
|
CAS | NA | |
PubChem CID | 25202506 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 347.4 | ALogp: | 0.9 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 107.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 25 | QED Weighted: | 0.523 |
Caco-2 Permeability: | -5.924 | MDCK Permeability: | 0.00001080 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.868 |
Human Intestinal Absorption (HIA): | 0.03 | 20% Bioavailability (F20%): | 0.965 |
30% Bioavailability (F30%): | 0.46 |
Blood-Brain-Barrier Penetration (BBB): | 0.164 | Plasma Protein Binding (PPB): | 35.65% |
Volume Distribution (VD): | 0.304 | Fu: | 53.73% |
CYP1A2-inhibitor: | 0.002 | CYP1A2-substrate: | 0.925 |
CYP2C19-inhibitor: | 0.008 | CYP2C19-substrate: | 0.339 |
CYP2C9-inhibitor: | 0.007 | CYP2C9-substrate: | 0.08 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.109 |
CYP3A4-inhibitor: | 0.173 | CYP3A4-substrate: | 0.032 |
Clearance (CL): | 2.818 | Half-life (T1/2): | 0.472 |
hERG Blockers: | 0.069 | Human Hepatotoxicity (H-HT): | 0.68 |
Drug-inuced Liver Injury (DILI): | 0.048 | AMES Toxicity: | 0.009 |
Rat Oral Acute Toxicity: | 0.948 | Maximum Recommended Daily Dose: | 0.963 |
Skin Sensitization: | 0.101 | Carcinogencity: | 0.304 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.028 |
Respiratory Toxicity: | 0.971 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002541 | 0.718 | D0R7JT | 0.282 | ||||
ENC000794 | 0.595 | D0KR5B | 0.275 | ||||
ENC000143 | 0.563 | D04VIS | 0.271 | ||||
ENC002558 | 0.528 | D0L2LS | 0.267 | ||||
ENC002555 | 0.517 | D0IX6I | 0.264 | ||||
ENC001071 | 0.467 | D0I2SD | 0.259 | ||||
ENC002554 | 0.441 | D0Q6NZ | 0.252 | ||||
ENC002556 | 0.371 | D0D1SG | 0.252 | ||||
ENC002559 | 0.360 | D06AEO | 0.252 | ||||
ENC003162 | 0.289 | D0P0HT | 0.250 |